Allogeneic major histocompatibility complex‐mismatched equine bone marrow‐derived mesenchymal stem cells are targeted for death by cytotoxic anti‐major histocompatibility complex antibodies

BACKGROUND: Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating musculoskeletal injuries in horses. Controversy exists, however, over whether major histocompatibility complex (MHC)‐mismatched MSCs are recognised by the recipient immune system and targeted for death by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Berglund, A.K., Schnabel, L.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Experimental and Basic Research Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425313/
https://www.ncbi.nlm.nih.gov/pubmed/27862236
http://dx.doi.org/10.1111/evj.12647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425313/
https://www.ncbi.nlm.nih.gov/pubmed/27862236
http://dx.doi.org/10.1111/evj.12647

Ejemplares similares